Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
Research context
Quantum Genomics Société Anonyme appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Quantum Genomics Société Anonyme is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.
From a valuation standpoint, the stock is 62.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 102.2.
Finally, its free cash flow fell by 43.8% to $-3M since the same quarter in the previous year.
Based on the above factors, Quantum Genomics Société Anonyme gets an overall score of 1/5.